Ultima-AOD9604 2mg

MANUFACTURER Ultima Pharmaceuticals - US
WAREHOUSE USA Warehouse 5
SUBSTANCE AOD 9604 - Anti-Obesity Drug

For your privacy and security, products are shipped without brand labeling.

AOD 9604, also known as GH Frag 176-191, is a powerful peptide derived from Growth Hormone, specifically engineered to replicate the last 15 amino acids (176-191) of the Growth Hormone polypeptide. This innovative formulation is celebrated as one of the most effective peptides for weight loss, delivering remarkable benefits such as improved fat reduction and a boosted metabolism.

Pituitary Gland

- Effectively reduces body fat - Facilitates fat release from obese cells more efficiently than from lean cells - Mimics natural growth hormone's fat metabolism regulation - Maintains stable blood sugar levels and does not hinder growth - Stimulates lipolysis (fat breakdown) - Inhibits lipogenesis (fat storage from non-fat foods) - Supports cartilage repair and regeneration, especially when combined with peptide BPC 157.

AOD-9604, or Tyr-hGH Frag 176-191, is renowned for its exceptional fat-burning properties without triggering overeating. Unlike other peptides, it does not affect blood sugar levels or promote tissue growth. AOD-9604 activates fat degradation and oxidation through a unique mechanism that bypasses hGH receptors, operating independently of hGH. Extensive research involving various species, including rodents and humans, indicates that AOD-9604 encourages fat release from predominantly obese fat cells, reduces new fat accumulation, and accelerates fat burning, with a notable impact on abdominal fat reduction.

While CJC-1295 is another potent fat-loss peptide that enhances overall GH levels to counteract age-related decline, it's important to note that GHRPs (like GHRP-6, GHRP-2, or GHRH) may increase hunger and cortisol levels. In contrast, AOD-9604 does not cause increased appetite or elevated cortisol.

Developed in the 1990s by Professor Frank Ng at Monash University in Australia, AOD-9604 was designed to offer the fat-burning benefits of human growth hormone (HGH) without the muscle-building effects. Recent research underscores its potential not only for weight loss but also for regenerative applications related to growth hormone. Ongoing studies are investigating AOD 9604's efficacy in treating osteoarthritis, hypercholesterolemia, and promoting the repair of bone and cartilage.

Results from oral glucose tolerance tests reveal that, unlike HGH, AOD 9604 does not negatively impact carbohydrate metabolism. Furthermore, no anti-AOD 9604 antibodies were detected in patients, and there were no reported serious adverse events in studies involving this peptide.

AOD 9604 presents an excellent safety and tolerability profile, akin to that of a placebo. It avoids the side effects commonly associated with full-length hGH treatments and has a strong safety record, recently earning Human GRAS status in the USA.